Literature DB >> 21470525

Highlights from the canadian bladder cancer network.

D Robert Siemens.   

Abstract

Entities:  

Year:  2011        PMID： 21470525      PMCID： PMC3104431          DOI： 10.5489/cuaj.11040

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  7 in total

1.  Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.

Authors:  Wassim Kassouf; Ashish M Kamat; Alexander Zlotta; Bernard H Bochner; Ronald Moore; Alan So; Jonathan Izawa; Ricardo A Rendon; Louis Lacombe; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2010-06       Impact factor: 1.862

2.  Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.

Authors:  Venu Chalasani; Wassim Kassouf; Joseph L Chin; Yves Fradet; Armen G Aprikian; Adrian S Fairey; Eric Estey; Louis Lacombe; Ricardo Rendon; David Bell; Ilias Cagiannos; Darrell Drachenberg; Jean-Baptiste Lattouf; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

3.  Emerging novel therapies in the treatment of castrate-resistant prostate cancer.

Authors:  Alym Abdulla; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

4.  Multivariate analysis of the factors involved in loss of renal differential function after laparoscopic partial nephrectomy: a role for warm ischemia time.

Authors:  Frédéric Pouliot; Allan Pantuck; Annie Imbeault; Brian Shuch; Brian Calimlim; Jean-François Audet; David S Finley; Thierry Dujardin
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

5.  Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.

Authors:  Hans-Martin Fritsche; Maximilian Burger; Robert S Svatek; Claudio Jeldres; Pierre I Karakiewicz; Giacomo Novara; Eila Skinner; Stefan Denzinger; Yves Fradet; Hendrik Isbarn; Patrick J Bastian; Bjoern G Volkmer; Francesco Montorsi; Wassim Kassouf; Derya Tilki; Wolfgang Otto; Umberto Capitanio; Jonathan I Izawa; Vincenzo Ficarra; Seth Lerner; Arthur I Sagalowsky; Mark Schoenberg; Ashish Kamat; Colin P Dinney; Yair Lotan; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2009-09-12       Impact factor: 20.096

Review 6.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

Authors:  Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta
Journal:  Eur Urol       Date:  2008-04-30       Impact factor: 20.096

Review 7.  An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.

Authors:  Girish S Kulkarni; Oliver W Hakenberg; Juergen E Gschwend; George Thalmann; Wassim Kassouf; Ashish Kamat; Alexandre Zlotta
Journal:  Eur Urol       Date:  2009-09-01       Impact factor: 20.096
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.